Web of Science: 29 cites, Scopus: 32 cites, Google Scholar: cites,
Cell-Mediated Immune Responses to in vivo -Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
Coppola, Mariateresa (Leiden University Medical Center)
Villar-Hernández, Raquel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
van Meijgaarden, Krista E. (Leiden University Medical Center)
Latorre, Irene (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Muriel-Moreno, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
García-García, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Franken, Kees L. M. C. (Leiden University Medical Center)
Prat i Aymerich, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Stojanovic, Zoran (Universitat Autònoma de Barcelona. Departament de Medicina)
De Souza Galvão, Maria Luiza (Hospital Universitari Vall d'Hebron)
Millet, Joan Pau (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Sabriá, Josefina (Hospital de Sant Joan Despí Moisès Broggi)
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron)
Noguera-Julian, Antoni (Institut de Recerca Sant Joan de Déu)
Geluk, Annemieke (Leiden University Medical Center)
Domínguez, José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Ottenhoff, Tom H. M. (Leiden University Medical Center)

Data: 2020
Resum: A quarter of the global human population is estimated to be latently infected by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). TB remains the global leading cause of death by a single pathogen and ranks among the top-10 causes of overall global mortality. Current immunodiagnostic tests cannot discriminate between latent, active and past TB, nor predict progression of latent infection to active disease. The only registered TB vaccine, Bacillus Calmette-Guérin (BCG), does not adequately prevent pulmonary TB in adolescents and adults, thus permitting continued TB-transmission. Several Mtb proteins, mostly discovered through IFN-γ centered approaches, have been proposed as targets for new TB-diagnostic tests or -vaccines. Recently, however, we identified novel Mtb antigens capable of eliciting multiple cytokines, including antigens that did not induce IFN-γ but several other cytokines. These antigens had been selected based on high Mtb gene-expression in the lung in vivo, and have been termed in vivo expressed (IVE-TB) antigens. Here, we extend and validate our previous findings in an independent Southern European cohort, consisting of adults and adolescents with either LTBI or TB. Our results confirm that responses to IVE-TB antigens, and also DosR-regulon and Rpf stage-specific Mtb antigens are marked by multiple cytokines, including strong responses, such as for TNF-α, in the absence of detectable IFN-γ production. Except for TNF-α, the magnitude of those responses were significantly higher in LTBI subjects. Additional unbiased analyses of high dimensional flow-cytometry data revealed that TNF-α+ cells responding to Mtb antigens comprised 17 highly heterogeneous cell types. Among these 17 TNF-α+ cells clusters identified, those with CD8+TEMRA or CD8+CD4+ phenotypes, defined by the expression of multiple intracellular markers, were the most prominent in adult LTBI, while CD14+ TNF-α+ myeloid-like clusters were mostly abundant in adolescent LTBI. Our findings, although limited to a small cohort, stress the importance of assessing broader immune responses than IFN-γ alone in Mtb antigen discovery as well as the importance of screening individuals of different age groups. In addition, our results provide proof of concept showing how unbiased multidimensional multiparametric cell subset analysis can identify unanticipated blood cell subsets that could play a role in the immune response against Mtb.
Ajuts: European Commission 643381
Ministerio de Economía y Competitividad PI16/01912
Instituto de Salud Carlos III PI18/00411
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: IVE-TB antigens ; Mycobacterium tuberculosis (Mtb) ; TB ; LTBI ; Cytokines ; Cell responses
Publicat a: Frontiers in immunology, Vol. 11 (february 2020) , ISSN 1664-3224

DOI: 10.3389/fimmu.2020.00103
PMID: 32117257


15 p, 1.5 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2022-02-07, darrera modificació el 2025-10-24



   Favorit i Compartir